Cytokinetics shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.5M | 51k | 70.11 |
| 2023-12-31 | $5.3M | 63k | 83.48 |
| 2023-09-30 | $1.3M | 44k | 29.45 |
| 2023-06-30 | $1.6M | 49k | 32.62 |
| 2023-03-31 | $1.4M | 40k | 35.18 |
| 2022-12-31 | $1.5M | 34k | 45.81 |
| 2022-09-30 | $1.8M | 36k | 48.45 |
| 2022-06-30 | $1.4M | 35k | 39.30 |
| 2022-03-31 | $823k | 22k | 36.83 |
| 2021-12-31 | $1.0M | 23k | 45.58 |
| 2021-09-30 | $705k | 20k | 35.76 |
| 2021-06-30 | $339k | 17k | 19.78 |
| 2021-03-31 | $416k | 18k | 23.23 |
| 2020-12-31 | $392k | 19k | 20.76 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors